Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | MMP13 | P45452 | 2/20 | 0.51 |
| ▸ | MMP8 | P22894 | 1/20 | 0.51 |
| ▸ | MMP1 | P03956 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4818974 | 0.83 | EGFR (0.56) | ALDH1A1TSHRPOLBHTTNPSR1 | |
| SCHEMBL18790916 | 0.83 | MMP13 (0.53) | ALDH1A1HTTNPSR1PKMMMP13 | |
| SCHEMBL23370091 | 0.83 | TDP1 (0.53) | ALDH1A1HTTNPSR1PKMMMP13 | |
| SCHEMBL7215806 | 0.83 | ALDH1A1 (0.61) | ALDH1A1HSD17B10POLBHTTNPSR1 | |
| SCHEMBL4209577 | 0.81 | ALDH1A1 (0.59) | ALDH1A1HSD11B1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11574940 | 0.81 | CYP19A1 (0.50) | ALDH1A1POLBHTTNPSR1PKM | |
| Benzylsulfonylbenzene SCHEMBL780337 | 0.80 | TSHR (0.68) | ALDH1A1TSHRHSD17B10HTTLTA4H | |
| SCHEMBL257997 | 0.79 | MAPT (0.64) | ALDH1A1TSHRHSD17B10POLBLMNA | |
| SCHEMBL11697044 | 0.79 | ALDH1A1 (0.53) | ALDH1A1TSHRHSD17B10POLBHTT | |
| SCHEMBL6820212 | 0.79 | MMP8 (0.60) | ALDH1A1HSD17B10POLBHTTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692249-A1 | COLORING AGENT, COLORING COMPOSITION, AND METHOD FOR PRODUCING COLORING AGENT | Artience Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024204597-A1 | COLORING AGENT, COLORING COMPOSITION, AND METHOD FOR PRODUCING COLORING AGENT | ａｒｔｉｅｎｃｅ株式会社 | 2024-10-03 | — | — | WO | disclosed |
| US-20030207889-A1 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | OWEN DAVID ALAN (GB) | 2003-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207889-A1 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | MMP13, MMP2, MMP9 | ALDH1A1 408/4885TSHR 2905/4885HSD17B10 413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.